Comprehensive Geriatric Assessment in the Elderly Subjects (PROMISING)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05822154

Acronym

PROMISING

Enrollment

400

Registered

2023-04-20

Start date

2022-10-03

Completion date

2023-12-31

Last updated

2023-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ageing, Frailty

Keywords

ageing, comprehensive geriatric assessment, polypharmacy

Brief summary

The primary objective of this observational study is to verify, through a comprehensive geriatric assessment, the health status of a sample of elderly subjects.

Detailed description

The primary objective of this observational study is to verify, through a comprehensive geriatric assessment, the health status of a sample of elderly subjects. Short- to medium-term outcomes will also be evaluated through follow-up.

Interventions

OTHERcomprehensive geriatric assessment

The clinical, biological and functional characteristics will be collected in elderly subjects attending the hospitals of participating centers.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

65 Years to No maximum

Inclusion criteria

* subjects with 65 years or older

Exclusion criteria

* no informed consent

Design outcomes

Primary

Measure	Time frame	Description
Change in health conditions	Baseline, 3, 6 and 12 months later	The prevalence of comorbidities and their risk factors at time of enrolment
Change in prevalence of polypharmacy	Baseline, 3, 6 and 12 months later	Number of participants with polypharmacy. Polypharmacy will be defined as being on five or more medications at one time

Secondary

Measure	Time frame	Description
Change in frailty condition	Baseline, 3, 6 and 12 months later	Clinical Frailty Scale (CFS). The CFS divides patients into 9 classes from very fit (CFS=1) to terminally ill (CFS=9)
Change in functional capacity	Baseline, 3, 6 and 12 months later	Activity of Daily Living (ADL). A summary score ranges from 0 (low function, dependent) to 6 (high function, independent)
Change in physical performance	Baseline, 3, 6 and 12 months later	Physical performance will be ascertained using the Short Physical Performance Battery (SPPB). Summary scores range from 0-12 and higher scores denote higher physical performance
Change of cognitive function score	Baseline, 3, 6 and 12 months late	Mini-mental State Examination (0-30 points), the higher the score, the better the cognitive function

Countries

Italy

Contacts

Primary ContactAnna Rita Bonfigli, PhD

a.bonfigli@inrca.it00390718003719

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026